IPL344

· Immunity Pharma Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IPL344, covering 2025-01-10 to 2025-01-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of IPL344 in the Treatment of ALS Patients [Phase 1, Phase 2]